Lights and Shadows of Rituximab in Dermatology
Ashok Kumar, Geo Danny, Sane Roja Renuka, Arisha Salam
Journal of Pharmaceutical Research International · pp. 179–187 · Published 21 Dec 2021
10.9734/jpri/2021/v33i60B34602Abstract
Rituximab is a CD 20 monoclonal antibody drug used in various spectrum of diseases today. It has proven to be a boon, especially in the field of dermatology. Although Rituximab was initially introduced as a novel method to treat B-cell Non Hodgkin Lymphoma, its use has rapidly expanded to include a number of other Lymphomas and Autoimmune diseases.This review is to give a bird’s eye view of updates on rituximab. Conclusion: With its horizons expanding in dermatology, and with better information regarding its efficacy and safety profile, Rituximab has now become an approved first‑line therapy for pemphigus. In conclusion, Rituximab has proven to be a substantial boon for dermatologists in difficult to treat cases.
Cited by 0
No indexed citations yet.
Related research
- Phamrmacoligical Therapies for COVID-19: A Comprehensive Review from 2022 Updated Nih, IDSA and ICMR Guidelines — shares topic coverage
- Optimizing the Aggregation Propensity of Therapeutic Monoclonal Antibodies against Cancer and Autoimmune Diseases: A Computational Study — shares topic coverage
- Biopharmaceuticals: New yet Natural — shares topic coverage
- New Monoclonal Antibodies to Human IgA: Obtaining and Study of Biological Properties — shares topic coverage
- Downregulation of Gap Junctions in Astrocytes by Monoclonal Antibodies against the Second Extracellular Loop of Connexin-43 — shares topic coverage
Article metrics
Real usage data collected on this platform.
12
Page views
0
PDF downloads
2
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.